BPOM Approves Ivermectin as Covid-19 Therapeutic Drug
TEMPO.CO, Jakarta - The Indonesian Food and Drug Monitoring Agency or BPOM has finally granted the Emergency Use Authorization for anti-parasitic drug ivermectin as the therapeutic drug to support the Covid-19 treatment.
The approval was stipulated in the agency’s Circular concerning the distribution of drugs with an emergency use permit.
Based on the copy of the circular received by Bisnis.com from the special staffer of the SOE Minister, Arya Sinulingga, on Wednesday evening, July 14, the agency head decided to allow the use of eight drugs for Covid-19 treatment.
The Circular was inked by the BPOM head No. HK.02.02.1.2.07.21.281 of 2021 on the second amendment to the BPOM Decree No. HK.02.02.1.2.11.20.1126 of 2020.
Besides ivermectin, the circular noted seven other therapeutic drugs for Covid-19 treatment, viz. Remdesivir, Favipiravir, Oseltamivir, Immunoglobulin, Ivermectin, Tocilizumab, Azithromycin, and Dexamethasone.
Read also: Hopes and Fears for Ivermectin